These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34310444)

  • 1. Effect of Adjustment for Case Misclassification and Infection Date Uncertainty on Estimates of COVID-19 Effective Reproduction Number.
    Goldstein ND; Quick H; Burstyn I
    Epidemiology; 2021 Nov; 32(6):800-806. PubMed ID: 34310444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative Bayesian modeling to nowcast the effective reproduction number from line list data with missing symptom onset dates.
    Lison A; Abbott S; Huisman J; Stadler T
    PLoS Comput Biol; 2024 Apr; 20(4):e1012021. PubMed ID: 38626217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Three Tests for SARS-CoV-2 on a University Campus Estimated Jointly with Bayesian Latent Class Modeling.
    Perkins TA; Stephens M; Alvarez Barrios W; Cavany S; Rulli L; Pfrender ME
    Microbiol Spectr; 2022 Feb; 10(1):e0122021. PubMed ID: 35044220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time estimation and forecasting of COVID-19 cases and hospitalizations in Wisconsin HERC regions for public health decision making processes.
    Aravamuthan S; Mandujano Reyes JF; Yandell BS; Döpfer D
    BMC Public Health; 2023 Feb; 23(1):359. PubMed ID: 36803324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basic reproduction number of COVID-19 across Africa.
    Iyaniwura SA; Rabiu M; David JF; Kong JD
    PLoS One; 2022; 17(2):e0264455. PubMed ID: 35213645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number.
    Eales O; Ainslie KEC; Walters CE; Wang H; Atchison C; Ashby D; Donnelly CA; Cooke G; Barclay W; Ward H; Darzi A; Elliott P; Riley S
    Epidemics; 2022 Sep; 40():100604. PubMed ID: 35780515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experience.
    Bsat R; Chemaitelly H; Coyle P; Tang P; Hasan MR; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Nasrallah GK; Benslimane FM; Al Khatib HA; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R; Abu-Raddad LJ; Ayoub HH
    J Glob Health; 2022; 12():05004. PubMed ID: 35136602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models.
    Whittaker DG; Herrera-Reyes AD; Hendrix M; Owen MR; Band LR; Mirams GR; Bolton KJ; Preston SP
    J Theor Biol; 2023 Feb; 558():111337. PubMed ID: 36351493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics.
    Furuse Y; Ko YK; Ninomiya K; Suzuki M; Oshitani H
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021.
    Tran TN; Wikle NB; Yang F; Inam H; Leighow S; Gentilesco B; Chan P; Albert E; Strong ER; Pritchard JR; Hanage WP; Hanks EM; Crawford FW; Boni MF
    JAMA Netw Open; 2022 May; 5(5):e2214171. PubMed ID: 35616938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Braithwaite I; Aldridge RW; Hayward AC; White P; Jombart T; Cori A
    Lancet; 2022 Nov; 400 Suppl 1():S40. PubMed ID: 36929985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States.
    Mallela A; Neumann J; Miller EF; Chen Y; Posner RG; Lin YT; Hlavacek WS
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak.
    Park SW; Bolker BM; Champredon D; Earn DJD; Li M; Weitz JS; Grenfell BT; Dushoff J
    J R Soc Interface; 2020 Jul; 17(168):20200144. PubMed ID: 32693748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obtaining Prevalence Estimates of Coronavirus Disease 2019: A Model to Inform Decision-Making.
    Sahlu I; Whittaker AB
    Am J Epidemiol; 2021 Aug; 190(8):1681-1688. PubMed ID: 33831172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the effect of mobility on SARS-CoV-2 transmission during the first and second wave of the COVID-19 epidemic, Switzerland, March to December 2020.
    Lison A; Persson J; Banholzer N; Feuerriegel S
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining Reproduction Number Estimates to Account for Unobserved Generations of Infection in Emerging Epidemics.
    Brizzi A; O'Driscoll M; Dorigatti I
    Clin Infect Dis; 2022 Aug; 75(1):e114-e121. PubMed ID: 35176766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission dynamics of the COVID-19 epidemic in England.
    Liu Y; Tang JW; Lam TTY
    Int J Infect Dis; 2021 Mar; 104():132-138. PubMed ID: 33359440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in how interventions coupled with effective reproduction numbers account for marked variations in COVID-19 epidemic outcomes.
    Xia F; Xiao Y; Liu PY; Cheke RA; Li XY
    Math Biosci Eng; 2020 Jul; 17(5):5085-5098. PubMed ID: 33120541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.